🇺🇸 FDA
Patent

US 7592453

Fused quinoline derivative and use thereof

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7592453 (Fused quinoline derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/08, A61P1/12